- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Stabicon Life Sciences covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (100), financial health (35), director (55) and company-foundation signals.
- Operating for 16+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Loss-making in FY 2023.
- Positive net worth.
- 2 directors on the board.
- Director PALANIANDY KRISHNAMURTHY has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Stabicon Life Sciences
Stabicon Life Sciences is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U73100KA2010PTC052428). Business overview includes Pharma (Pharma Contract R&D), incorporated on February 09, 2010 (16+ years old), headquartered in Bengaluru, Karnataka, India. The company is currently Active with Active Compliant compliance status.
- Location #4M-413, Hrbr Layout,3Rd Block, Kamanahalli Main Road ,Kalyan Nagar, Bengaluru, Karnataka - 560043
- Website stabicon.com
Financial Performance of Stabicon Life Sciences
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Stabicon Life Sciences (2)
Charges of Stabicon Life Sciences
| Lender | Amount | Status |
|---|---|---|
|
Others
Creation Date: 24 Oct 2025 |
10.00 cr | Open |
|
Others
Creation Date: 26 Sep 2020 |
27.88 Lakh | Closed |
|
State Bank Of India
Creation Date: 28 Feb 2011 |
3.32 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Professional, Scientific and Technical | - | 100 |
| Professional, Scientific and Technical | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Legal Cases of Stabicon Life Sciences
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
